Research projects in progress
Novel therapies in pediatric neurodegeneration with energy metabolism dysfunction: MENCIA LAB.
The growing incidence of neurodegenerative diseases represents a huge challenge, and their understanding requires multidisciplinary approaches. …
Execution: 
25%
Development of alternative therapies for the treatment of combined oxidative phosphorylation deficiency Type 1 (COXPD1) caused by mutations in GFM1.
The MGD group studies regulation in diseases in a broad context, ranging from inherited diseases to those related to aging…..
Execution: 
0%
Development of new gene therapy strategies to treat mitochondrial diseases
Hepatoencephalopathy due to the combined deficiency of oxidative phosphorylation type 1 (COXPD1) is caused by mutations in the nuclear gene GFM1…
Execution: 
50%
Mitocure project 2018
Las enfermedades mitocondriales abarcan un amplio espectro de trastornos musculares y neurodegenerativos, crónicos y progresivos, causadas por mutaciones en el ADN nuclear…
Execution: 
75%
Creation of an animal model
Creation of a knockin mouse for a mutation in the GFM1 gene as a study model of hepatic encephalopathy caused by dysfunction of the mitochondrial elongation factor G1…
Execution: 75%